Oramed Pharmaceuticals Profit Margin 2011-2019 | ORMP
Current and historical gross margin, operating margin and net profit margin for Oramed Pharmaceuticals (ORMP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Oramed Pharmaceuticals net profit margin as of May 31, 2019 is -568.43%.
|Oramed Pharmaceuticals Annual Profit Margins
|Oramed Pharmaceuticals Quarterly Profit Margins
||Medical Products Manufacturing
Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.